2026-09-10 · 2026-09 / week-2
Korn Ferry beat Q1, but AMS claims keep the rebound a no-trade
Korn Ferry beat Q1, but AMS claims keep the rebound a no-trade
Run timestamp: 2026-09-10 08:00 SGT Scope: U.S. market, long only Classification: No-trade screen, Reject for current execution Primary instrument: Korn Ferry common stock, NYSE, unlevered only if every gate later passes
Summary: Korn Ferry's fiscal Q1 2027 results beat consensus: revenue was $764.6 million, fee revenue grew 7% to $756 million, adjusted EBITDA rose 7% to $128 million, and adjusted EPS was $1.43. Estimated remaining contract fees grew 14% to $1.92 billion and new business rose 12%. The stock closed at $81.13 on September 9, down 1.12%, because Q2 guidance includes only two AMS months and lower margins with incremental amortization, interest, and shares.
The reference-only map is $105/$95/$68 at 25%/50%/25%. Base move is +17.10%, adverse path -16.20%, and gross reward to adverse risk 1.06:1. KFY is research context, not a qualified long.
Opportunity Ranking
| Rank | Candidate | Direction | Mispricing | Evidence Freshness | Catalyst Window | Positioning | 10/5 Status | Tradeability | Main Rejection Risk |
|---|---|---|---|---|---|---|---|---|---|
| 1 | KFY | Long | Q1 beat and contract visibility meet a decline, but AMS adds claims before full cash proof | Sep. 9 8-K and tape | Q2 AMS contribution and debt bridge | Current market positioning incomplete | Base +17.10%, adverse -16.20%, ratio 1.06:1, Reject | NYSE tape; spread, depth, and exit audit missing | AMS integration, interest, amortization, labor cycle |
| 2 | SUNB | Long | Record Q1 and raised guide meet a 5.8% rally, but capex is heavy | Sep. 9 primary release and tape | Fleet and FCF conversion | Incomplete | Reject | Live book missing | Fleet returns, capex, debt |
| 3 | SIG | Long | Comp growth and raised EPS meet a 23.9% surge | Sep. 9 primary release and tape | Holiday and ASR settlement | Incomplete | Reject | Exit audit missing | Tariff refunds, gold, credit |
Selected opportunity: KFY, long research only. Why this one now: New Q1 evidence proves a beat while quantifying AMS's near-term claims. What should surprise the reader: More contract fees can improve visibility while reducing near-term per-share clarity.
Why This Is the Best Opportunity Right Now
The Q1 FY27 release reported $764.6 million revenue, $756 million fee revenue, $128 million adjusted EBITDA, $1.43 adjusted EPS, $1.92 billion remaining fees, and 12% new-business growth. Q2 guidance is $860 million to $878 million fee revenue, 16.8% to 17.2% adjusted EBITDA margin, and $1.30 to $1.40 adjusted EPS, with only two AMS months and incremental amortization, interest, and shares.
10/5 Asymmetry Gate
| Measure | Reference-only result | Interpretation |
|---|---|---|
| Reference price | $81.13 | Sep. 9 close |
| Base target | $95.00 | +17.10% |
| Bottom target | $68.00 | -16.20% |
| Gross reward to adverse risk | 1.06:1 | Fails 2:1 |
| Probability-weighted target | $87.50 | +7.86% before costs |
| Status | Reject | No trade |
What Should Surprise the Reader
AMS is not free growth. Acquired revenue arrives with amortization, interest, and new shares before its cash bridge is proven.
The Mispricing
Fact: Q1 beat and remaining fees grew. Fact: Q2 includes explicit acquisition claims. Inference: The market may be discounting acquired earnings before cash conversion is observable. Unknown: Current AMS debt, integration costs, cash, shares, and Q2 working capital.
The Positioning
Prior provider data showed 2.22 million shares short and 5.92 DTC. Current settlement, borrow, options, dealer, flows, and holders were not verified. Positioning score: 2/5.
The Catalyst
Q2 tests AMS fee conversion, cross-selling, margin, debt, interest, amortization, cash, shares, and legacy labor demand. The next regular sessions test price acceptance and exit liquidity.
Price Target and Probability Map
| Scenario | Probability | Target | Return | Conditions |
|---|---|---|---|---|
| Top | 25% | $105 | +29.54% | AMS cross-sell and margin hold |
| Base | 50% | $95 | +17.10% | Guide delivery and stable cash |
| Bottom | 25% | $68 | -16.20% | Integration, interest, or labor reset |
Probability-weighted expected value: $87.50, or +7.86% before costs. 10/5 status: Reject; entry null and execution blocked.
The Kill Shot
The counterparty view is that AMS raises revenue while lowering near-term margin and EPS. The long fails unless cross-selling and contracts outrun debt, amortization, and share claims.
What Could Go Wrong
- AMS fees fail to convert.
- Interest and amortization reduce per-share earnings.
- Legacy labor demand slows.
- Cash goes to debt and integration.
- Market structure remains unverified.
Best Trade Strategy
No trade. Keep entry.price null and execution.can_execute false. No options, leverage, margin, market orders, or price-floor logic.
Sources
- Korn Ferry Q1 FY27 results, Sep. 9, 2026.
- Korn Ferry Q1 2027 8-K, Sep. 9, 2026.
- KFY quote context, Sep. 9, 2026.
- SUNB Q1 FY27 results, Sep. 9, 2026.
- SIG Q2 FY27 results, Sep. 9, 2026.
Research Quality Scorecard
| Criterion | Score |
|---|---|
| Market disagreement | 4/5 |
| Evidence base | 4/5 |
| Positioning and flows | 2/5 |
| Catalyst path | 5/5 |
| Payoff architecture | 3/5 |
| Invalidation discipline | 5/5 |
| Differentiated insight | 4/5 |
| Client value | 5/5 |
| Total | 32/40 |
Bottom Line
Korn Ferry beat Q1, but AMS adds claims before a full quarter of earnings. The base is +17.10%, adverse risk is -16.20%, and reward-to-risk is 1.06:1. Reject the long until AMS cash conversion, debt, shares, and Q2 margins are filed.
AI Illustration Prompt
Create an institutional editorial illustration of a consulting valuation desk with a bright Q1 earnings ledger beside an AMS acquisition folder. Show contract-fee bars rising while debt, amortization, interest, and new-share documents weigh down a per-share scale. Use charcoal, paper cream, muted blue, restrained amber, and a subtle readable “The Mispricing Desk” watermark.